Annual report
2689.TEDINET S100WQ48
Period2024-07-01 → 2025-06-30
Filed2025-09-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥122.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥118.6bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥110.5bn | 2022-07-01 → 2023-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.1bn | 2020-07-01 → 2021-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2023-07-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2023-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2020-07-01 → 2021-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.9bn | 2024-07-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.2bn | 2023-07-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2023-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥989m | 2020-07-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥45.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥43.2bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥40.9bn | at 2023-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥40.0bn | at 2022-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥36.6bn | at 2021-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.6bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥31.9bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥12.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2023-06-30v | Cons. | Net assets |
| Net assets / equity | ¥9.1bn | at 2022-06-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥8.1bn | at 2021-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2022-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.1bn | at 2021-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥660m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.4bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.1bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥673m | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥306m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥212m | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥630m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥687m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥176m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.3bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥241.43 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥251.68 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥234.9 | 2022-07-01 → 2023-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.66 | 2020-07-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,068.59 | at 2025-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,922.58 | at 2024-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,712.19 | at 2023-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,513.91 | at 2022-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,336.91 | at 2021-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 26.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.3% | at 2023-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.2% | at 2021-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.1% | 2024-07-01 → 2025-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2023-07-01 → 2024-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.6% | 2022-07-01 → 2023-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2021-07-01 → 2022-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2020-07-01 → 2021-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,393 | at 2025-06-30 | Cons. | Number of employees |
| Employees | 1,354 | at 2024-06-30 | Cons. | Number of employees |
| Employees | 1,317 | at 2023-06-30v | Cons. | Number of employees |
| Employees | 1,289 | at 2022-06-30v | Cons. | Number of employees |
| Employees | 1,261 | at 2021-06-30d | Cons. | Number of employees |
| Revenue | ¥2.7bn | 2024-07-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥2.2bn | 2023-07-01 → 2024-06-30 | Standalone | Net sales |
| Revenue | ¥1.9bn | 2022-07-01 → 2023-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2021-07-01 → 2022-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2020-07-01 → 2021-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2024-07-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | ¥661m | 2023-07-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | ¥1.2bn | 2024-07-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥672m | 2023-07-01 → 2024-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥631m | 2022-07-01 → 2023-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-07-01 → 2022-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥477m | 2020-07-01 → 2021-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2024-07-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥672m | 2023-07-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | ¥1.1bn | 2024-07-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | ¥592m | 2023-07-01 → 2024-06-30 | Standalone | Profit loss |
| Net income | ¥549m | 2022-07-01 → 2023-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥999m | 2021-07-01 → 2022-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥384m | 2020-07-01 → 2021-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥10.5bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥8.5bn | at 2024-06-30 | Standalone | Assets |
| Total assets | ¥8.1bn | at 2023-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.9bn | at 2022-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.8bn | at 2021-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.1bn | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥3.6bn | at 2024-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.4bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2024-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.9bn | at 2023-06-30v | Standalone | Net assets |
| Net assets / equity | ¥4.7bn | at 2022-06-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.1bn | at 2021-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥861m | at 2024-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥183.4 | 2024-07-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.31 | 2023-07-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.25 | 2022-07-01 → 2023-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥164.46 | 2021-07-01 → 2022-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.17 | 2020-07-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2024-07-01 → 2025-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2023-07-01 → 2024-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-07-01 → 2023-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-07-01 → 2022-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-07-01 → 2021-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥917.19 | at 2025-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥815.07 | at 2024-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥809.18 | at 2023-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥775.62 | at 2022-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥673.94 | at 2021-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 51.7% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.1% | at 2023-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2021-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.2% | 2024-07-01 → 2025-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2023-07-01 → 2024-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2022-07-01 → 2023-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.8% | 2021-07-01 → 2022-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2020-07-01 → 2021-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,250,000 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2023-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2022-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2021-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 50 | at 2025-06-30 | Standalone | Number of employees |
| Employees | 51 | at 2024-06-30 | Standalone | Number of employees |
| Employees | 47 | at 2023-06-30v | Standalone | Number of employees |
| Employees | 41 | at 2022-06-30v | Standalone | Number of employees |
| Employees | 39 | at 2021-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 71
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-07-01 → 2025-06-30 | ¥122m |
| Reconciling Itemsreconciling | depreciation | 2024-07-01 → 2025-06-30 | ¥22m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment assets | at 2025-06-30 | −¥3.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2025-06-30 | −¥113m |
| Care Nursing Goodsreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥19m |
| Care Nursing Goodsreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥8m |
| Care Nursing Goodsreportable segment | employees | at 2025-06-30 | 153 pure |
| Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥2.8bn |
| Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥2.8bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥144,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2025-06-30 | ¥1.2bn |
| Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥205m |
| Medical Equipmentreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥1.6bn |
| Medical Equipmentreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥571m |
| Medical Equipmentreportable segment | employees | at 2025-06-30 | 1011 pure |
| Medical Equipmentreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥115.9bn |
| Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥114.3bn |
| Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥1.5bn |
| Medical Equipmentreportable segment | segment assets | at 2025-06-30 | ¥42.7bn |
| Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥1.8bn |
| SPDreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥27m |
| SPDreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥24m |
| SPDreportable segment | employees | at 2025-06-30 | 179 pure |
| SPDreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥5.7bn |
| SPDreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥5.6bn |
| SPDreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥129m |
| SPDreportable segment | segment assets | at 2025-06-30 | ¥6.0bn |
| SPDreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥114m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-07-01 → 2025-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-07-01 → 2025-06-30 | ¥603m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2025-06-30 | ¥124.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2025-06-30 | ¥122.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-06-30 | ¥49.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2025-06-30 | ¥2.1bn |
| Reconciling Itemsreconciling | capex | 2023-07-01 → 2024-06-30 | ¥99m |
| Reconciling Itemsreconciling | depreciation | 2023-07-01 → 2024-06-30 | ¥27m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2024-06-30 | −¥1.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2024-06-30 | −¥1.5bn |
| Reconciling Itemsreconciling | segment assets | at 2024-06-30 | −¥3.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2024-06-30 | −¥124m |
| Care Nursing Goodsreportable segment | capex | 2023-07-01 → 2024-06-30 | ¥7m |
| Care Nursing Goodsreportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥5m |
| Care Nursing Goodsreportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥2.6bn |
| Care Nursing Goodsreportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥2.6bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥1m |
| Care Nursing Goodsreportable segment | segment assets | at 2024-06-30 | ¥1.2bn |
| Care Nursing Goodsreportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥209m |
| Medical Equipmentreportable segment | capex | 2023-07-01 → 2024-06-30 | ¥508m |
| Medical Equipmentreportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥500m |
| Medical Equipmentreportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥112.2bn |
| Medical Equipmentreportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥110.8bn |
| Medical Equipmentreportable segment | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥1.3bn |
| Medical Equipmentreportable segment | segment assets | at 2024-06-30 | ¥39.9bn |
| Medical Equipmentreportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥2.0bn |
| SPDreportable segment | capex | 2023-07-01 → 2024-06-30 | ¥21m |
| SPDreportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥22m |
| SPDreportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥5.2bn |
| SPDreportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥5.1bn |
| SPDreportable segment | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥134m |
| SPDreportable segment | segment assets | at 2024-06-30 | ¥5.8bn |
| SPDreportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥105m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-07-01 → 2024-06-30 | ¥536m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-07-01 → 2024-06-30 | ¥527m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2024-06-30 | ¥120.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2024-06-30 | ¥118.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-06-30 | ¥47.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2024-06-30 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,638
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | CurrentYearInstant | 45871212000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 1336.91 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 1513.91 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 1712.19 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 1922.58 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 2068.59 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 162.66 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 252.80 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 234.90 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 251.68 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 241.43 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.222 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.228 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.253 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.263 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.267 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.128 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.178 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.146 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.138 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.121 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 10.17 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 6.63 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 7.70 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 8.01 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 8.30 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 3126307000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 2420642000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -659519000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 2084226000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 1626920000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -630379000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -211806000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -306247000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -673033000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -1635697000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -2262540000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -1169906000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 175938000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -1089783000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | 686949000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 2110675000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 3149605000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 2359777000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2681186000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |